All data are based on the daily closing price as of July 22, 2024
f

Foresee Pharmaceuticals

6576.TWO
2.48 USD
-0.04
-1.59%

Overview

Last close
2.48 usd
Market cap
337.68M usd
52 week high
4.20 usd
52 week low
2.39 usd
Target price
4.66 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
68.8702
Price/Book Value
10.8478
Enterprise Value
315.47M usd
EV/Revenue
63.4559
EV/EBITDA
-13.5681

Key financials

Revenue TTM
8.23M usd
Gross Profit TTM
8.40M usd
EBITDA TTM
-27.68M usd
Earnings per Share
-0.23 usd
Dividend
N/A usd
Total assets
52.78M usd
Net debt
N/A usd

About

Foresee Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, engages in the development and commercialization of drugs in the United States, China, and Europe. The company's stabilized injectable formulation pipeline includes FP-001, which completed Phase III clinical study for the treatment of advanced stage prostate cancer; FP-004 that is in preclinical stage to treat opioids use disorder; FP-011 and FP-014, a long-acting sustained release dosage form for the treatment of breast cancer/prostate cancer; and FP-016 for the treatment of neurological diseases. Its new chemical entity pipeline products consist of FP-020 to treat sarcoidosis, idiopathic pulmonary fibrosis, and pulmonary emphysema; FP-025, a selective matrix metalloproteinase-12 inhibitor, which is in Phase II clinical trial for the treatment of asthma, chronic obstructive pulmonary diseases, and acute respiratory distress syndrome in COVID-19 patients; and FP-045, a selective aldehyde dehydrogenase (ALDH2) activator that completed Phase I clinical study for the treatment of fanconi anemia, as well as FP-040, an ALDH2 activator to treat central nervous system diseases. Foresee Pharmaceuticals Co., Ltd. was incorporated in 2013 and is based in Taipei, Taiwan.
  • Symbol
    6576.TWO
  • Exchange
    TWO
  • Isin
    TW0006576002
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Dr. Benjamin Chien
  • Headquarter
    Taipei
  • Web site
    https://www.foreseepharma.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top